See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645569_2022_DICE_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001645569, DICE Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 323,911,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,645,000 |
| 3 | remainder_Assets | 198,000 |
| 4 | LiabilitiesCurrent | 10,881,000 |
| 5 | LiabilitiesNoncurrent | 1,916,000 |
| 6 | remainder_Liabilities | 8,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,222,000 |
| 9 | ResearchAndDevelopmentExpense | 36,506,000 |
| 10 | remainder_Expenses | 1,492,000 |
| 11 | remainder_Revenues | 1,125,000 |
| 12 | remainder_NetIncome | 136,000 |
| 13 | remainder_ComprehensiveNetIncome | -58,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 325,754,000 |
| 1 | Liabilities | 12,805,000 |
| 2 | Expenses | 50,220,000 |
| 3 | Revenues | 1,125,000 |
| 4 | StockholdersEquity | 312,949,000 |
| 5 | NetIncome | -48,959,000 |
| 6 | ComprehensiveNetIncome | -48,988,000 |
| 7 | BaseVar | 195,049,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.74 |
| 9 | EconomicCapitalRatio | 4.20 |
Edgar->Model Mapping
Feature Distribution
